Medical Experts Urge Higher Hpv Vaccination Rates In Quebec

The Importance Of Hpv Prevention

A prominent Montreal physician and researcher is raising concerns regarding the vaccination rates for the human papillomavirus (HPV) among the population in Quebec. Dr. Marc Steben, a board member of the International Human Papillomavirus Society, emphasizes that not enough individuals are receiving the necessary vaccinations to protect themselves from this common infection. HPV is identified as the most frequent infection of its kind, with estimates suggesting it affects three out of every four people in Quebec.

The primary concern for health professionals is the direct link between HPV and the development of cervical cancer, as well as other types of malignancies. Dr. Steben argues that the prevalence of the virus would be significantly lower if the general public possessed a better understanding of the available protection methods. He advocates for a clear and consistent public health message, stating that the disease is highly preventable through a combination of strategic vaccination and regular screening. According to Steben, the region should be at the forefront of providing access to these preventative measures to ensure long-term public health success.

The Path Toward Eliminating Cervical Cancer

Investing in the prevention of cervical cancer is viewed by experts as one of the most critical health investments. Dr. Steben suggests that with sustained progress over the next two decades, cervical cancer could become so rare that traditional screening might eventually cease to be necessary. However, he maintains that vaccination must continue for younger generations to maintain this progress and prevent future outbreaks.

While the long-term goal is elimination, current data suggests challenges remain. Reports indicate that Canada may struggle to meet its goal of eliminating cervical cancer by 2040. After a period of steady decline, the rate of this cancer has stagnated. It is estimated that in 2025, approximately 1,650 people in Canada will be diagnosed with cervical cancer, resulting in about 430 deaths. Dr. Denis Soulières, a hematologist-oncologist and spokesperson for the Canadian Cancer Society, notes that while he expected the problem to be under control after 30 years of practice, that has not yet fully materialized.

Regional data shows that Quebec and New Brunswick are expected to have some of the lowest rates of cervical cancer in 2025, at approximately 7.8 cases per 100,000 people. This is notably lower than rates projected for Newfoundland and Labrador or Saskatchewan. Despite these lower rates, experts believe there is still significant room for improvement in how screening is promoted and accessed.

Transitioning To Advanced Screening Methods

To combat the stagnation in cancer decline, Quebec is transitioning its screening protocols. The traditional Pap test is being replaced by the HPV screening test, which is considered more accurate in detecting potential malignancies. This new test is performed every five years rather than more frequently. The transition is already underway, with the goal of having all regions in Quebec adopt the HPV test by 2026.

However, access remains an issue. Dr. Soulières points out that a large portion of the population, particularly in the Montreal area, still lacks access to the HPV test. He suggests that the introduction of this new technology should be accompanied by better promotion to ensure higher uptake among the population. Some experts have compared the current uptake of cervical screening unfavorably to the rates seen with mammography.

To increase accessibility, Quebec has initiated pilot projects that allow women to use HPV testing kits at home. While some experts argue that self-testing is as effective as clinic-based testing, Dr. Soulières suggests that an initial visit with a clinician is necessary to ensure the patient understands the process and the importance of the screening. Current vaccination participation rates in Quebec are estimated between 76 and 80 per cent, and health officials hope to maintain these high levels as the effects of these programs become more evident in the coming years.